These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30805315)
21. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo. Ogbomo H; Zemp FJ; Lun X; Zhang J; Stack D; Rahman MM; McFadden G; Mody CH; Forsyth PA PLoS One; 2013; 8(6):e66825. PubMed ID: 23762498 [TBL] [Abstract][Full Text] [Related]
22. Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines. Nichols AC; Yoo J; Um S; Mundi N; Palma DA; Fung K; Macneil SD; Koropatnick J; Mymryk JS; Barrett JW Intervirology; 2014; 57(1):17-22. PubMed ID: 23942307 [TBL] [Abstract][Full Text] [Related]
23. Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells. Thakur S; Ruan Y; Zhang C; Lun X; Jayanthan A; Narendran A Cancer Gene Ther; 2021 Aug; 28(7-8):739-744. PubMed ID: 32678303 [TBL] [Abstract][Full Text] [Related]
24. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus. Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040 [TBL] [Abstract][Full Text] [Related]
25. [Oncolytic virus therapy for malignant brain tumors]. Ino Y; Todo T Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859 [TBL] [Abstract][Full Text] [Related]
26. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies. Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859 [TBL] [Abstract][Full Text] [Related]
28. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533 [TBL] [Abstract][Full Text] [Related]
29. Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Guo ZS; Liu Z; Sathaiah M; Wang J; Ravindranathan R; Kim E; Huang S; Kenniston TW; Bell JC; Zeh HJ; Butterfield LH; Gambotto A; Bartlett DL Mol Ther Methods Clin Dev; 2017 Dec; 7():112-122. PubMed ID: 29085848 [TBL] [Abstract][Full Text] [Related]
30. Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. Ottolino-Perry K; Tang N; Head R; Ng C; Arulanandam R; Angarita FA; Acuna SA; Chen Y; Bell J; Dacosta RS; McCart JA Int J Cancer; 2014 Feb; 134(3):717-30. PubMed ID: 23893655 [TBL] [Abstract][Full Text] [Related]